Licensing opportunity
Researchers at Strathclyde University, Scotland have developed an oral delivery system that provides controlled drug-release profiles without the need for expensive and time-consuming processes. The researchers say the technology provides a simple cost-effective platform that can be used to deliver combinations of drugs to the body at optimal times to maximise therapeutic benefit.
The oral drug delivery platform technology has the ability to deliver drug combinations in complex release patterns. The delivery device performs independently of gastrointestinal pH to allow time-specific release.
The system allows for a streamlined manufacturing process that is readily scaleable. The researchers say the system will improve patient compliance and has the potential to minimise drug-related side effects
Clinical areas for application of the technology include, but are not limited to, hypertension, asthma, anxiety, epilepsy, pain, sleep disorders and infections.
The university would like to hear from organisations interested in developing or exploiting the technology.
For more information, see this page at the University of Strathclyde.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
